FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家銀行調整部分加拿大能源基礎設施公司的估值

By

-- 加拿大皇家銀行資本市場（RBC Capital Markets）週一公佈了部分加拿大能源基礎設施公司在第一季財報季前的獲利預期調整。 RBC將Capital Power（CPX.TO）的EBITDA預期從3.6億加幣上調至4億加幣，同時將Keyera（KEY.TO）的EBITDA預期從2.6億加幣下調至2.1億加幣。 RBC指出，此舉是由於對沖交易的季節性變化及其相關影響。 RBC將Northland Power（NPI.TO）的EBITDA預期從4.05億加元上調至4.3億加元，以反映其對歐洲離岸風電資源成長的預期。 RBC將TransAlta（TA.TO）的EBITDA預期從2.35億加幣下調至2.17億加元，原因是該公司的發電量下降。 加拿大皇家銀行(RBC)將Emera (EMA.TO)的每股盈餘預期從1.17美元上調至1.20美元，主要原因是坦帕電力公司(Tampa Electric)的天氣狀況更為有利，以及價格波動高於預期。 加拿大皇家銀行將Enbridge (ENB.TO)的折現現金流預期從1.75美元下調至1.72美元，以反映加拿大能源監管機構(CER)的監管決定對其MTS財務回報計算的預期影響。 加拿大皇家銀行將Gibson Energy (GEI.TO)的EBITDA預期從1.54億美元下調至1.49億美元，主要原因是觀察到的航運活動減少。 加拿大皇家銀行將Hydro One (H.TO)的每股盈餘預期從0.58美元上調至0.64美元，原因是安大略省60分鐘高峰需求和費率基數成長高於預期。 RBC 將 Pembina (PPL.TO) 的 EBITDA 預期從 10.63 億美元上調至 10.97 億美元，主要原因是壓裂業務範圍的改善有利於行銷。

Price: $66.88, Change: $-0.37, Percent Change: -0.55%

Related Articles

Insider Trading

Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing

Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml

$LFST
Australia

Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.

$CLS
Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.

$AMP